Sanofi gets Dupixent approved for the treatment of COPD in the EU – MedWatch

Sanofi has received approval in Europe for the treatment of chronic obstructive pulmonary disease, COPD, with type 2 inflammation and chronic …

Share on Facebook

Tweet

Follow us

Save